Giuseppa Scandurra

1.3k total citations
47 papers, 498 citations indexed

About

Giuseppa Scandurra is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Giuseppa Scandurra has authored 47 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Genetics. Recurrent topics in Giuseppa Scandurra's work include HER2/EGFR in Cancer Research (9 papers), BRCA gene mutations in cancer (7 papers) and Ovarian cancer diagnosis and treatment (7 papers). Giuseppa Scandurra is often cited by papers focused on HER2/EGFR in Cancer Research (9 papers), BRCA gene mutations in cancer (7 papers) and Ovarian cancer diagnosis and treatment (7 papers). Giuseppa Scandurra collaborates with scholars based in Italy, United Kingdom and United States. Giuseppa Scandurra's co-authors include Luca Falzone, Massimo Libra, Francesco Torino, Silvia Vivarelli, Paolo Scollo, Alessandro Lavoro, Giuseppe Gattuso, Giuseppe Scibilia, Caterina Grillo and Paolo Zola and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Giuseppa Scandurra

41 papers receiving 487 citations

Peers

Giuseppa Scandurra
Steven S. Evans United States
Chun Gao China
Kimon Tzannis Greece
Amira Elbendary Egypt
Constantine Dimitrakakis Greece
Ensong Guo China
Anwei Lu China
Francis V. James India
Yoo‐Kyung Lee South Korea
Steven S. Evans United States
Giuseppa Scandurra
Citations per year, relative to Giuseppa Scandurra Giuseppa Scandurra (= 1×) peers Steven S. Evans

Countries citing papers authored by Giuseppa Scandurra

Since Specialization
Citations

This map shows the geographic impact of Giuseppa Scandurra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppa Scandurra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppa Scandurra more than expected).

Fields of papers citing papers by Giuseppa Scandurra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppa Scandurra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppa Scandurra. The network helps show where Giuseppa Scandurra may publish in the future.

Co-authorship network of co-authors of Giuseppa Scandurra

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppa Scandurra. A scholar is included among the top collaborators of Giuseppa Scandurra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppa Scandurra. Giuseppa Scandurra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sambataro, Daniela, et al.. (2025). A Practical Narrative Review on the Role of Magnesium in Cancer Therapy. Nutrients. 17(14). 2272–2272. 3 indexed citations
3.
Scaglione, Giovanni Luca, Maurizio Polano, Giuseppa Scandurra, et al.. (2025). Real-World Analysis of HRD Assay Variability in High-Grade Serous Ovarian Cancer: Impacts of BRCA1/2 Mutation Subtypes on HRD Assessment. Biomolecules. 15(5). 745–745.
4.
Valerio, Maria Rosaria, Federica Martorana, Daniela Sambataro, et al.. (2025). Real-World Analysis of Adherence to Abemaciclib and Endocrine Therapy in Women with HR+/HER2− Breast Cancer. Biomedicines. 13(3). 546–546. 2 indexed citations
5.
Sambataro, Daniela, Annalisa Quattrocchi, Giuseppe Caputo, et al.. (2025). Brain Metastasis in Endometrial Cancer: A Systematic Review. Cancers. 17(3). 402–402.
6.
Ricciardi, Giuseppina Rosaria Rita, Alessandro Russo, Antonio Russo, et al.. (2025). Efficacy and Safety Analysis of Nab-Paclitaxel Treatment in Elderly Patients with HER-2 Negative Metastatic Breast Cancer: NEREIDE Study. Cancers. 17(13). 2069–2069.
7.
8.
Cipolla, Calogero, et al.. (2024). Accuracy and Outcomes of Sentinel Lymph Node Biopsy in Male with Breast Cancer: A Narrative Review and Expert Opinion. Current Oncology. 31(12). 7566–7574. 1 indexed citations
9.
Falanga, Anna, Domenica Lorusso, Nicoletta Colombo, et al.. (2024). Gynecological Cancer and Venous Thromboembolism: A Narrative Review to Increase Awareness and Improve Risk Assessment and Prevention. Cancers. 16(9). 1769–1769. 2 indexed citations
10.
11.
Colombo, Alfredo, et al.. (2024). A Narrative Review of the Role of Immunotherapy in Metastatic Carcinoma of the Colon Harboring a BRAF Mutation. In Vivo. 39(1). 25–36. 1 indexed citations
12.
Scandurra, Giuseppa, Giuseppe Scibilia, Daniela Sambataro, et al.. (2024). New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful?. Cancers. 16(13). 2466–2466. 3 indexed citations
13.
Cipolla, Calogero, et al.. (2024). The Impact of Neoadjuvant Chemotherapy on Axillary Surgical Management of Patients With Breast Cancer and Positive Axillary Lymph Nodes. Anticancer Research. 44(5). 2047–2053. 1 indexed citations
14.
Lavalle, Salvatore, et al.. (2024). Unveiling the Intricate Dance: How Cancer Orchestrates Muscle Wasting and Sarcopenia. In Vivo. 38(4). 1520–1529. 5 indexed citations
15.
Lavalle, Salvatore, et al.. (2024). Immune checkpoint inhibitor therapy‑related pneumonitis: How, when and why to diagnose and manage (Review). Experimental and Therapeutic Medicine. 28(4). 381–381. 6 indexed citations
16.
Scaglione, Giovanni Luca, Sandro Pignata, Carmela Paolillo, et al.. (2023). Homologous Recombination Deficiency (HRD) Scoring, by Means of Two Different Shallow Whole-Genome Sequencing Pipelines (sWGS), in Ovarian Cancer Patients: A Comparison with Myriad MyChoice Assay. International Journal of Molecular Sciences. 24(23). 17095–17095. 4 indexed citations
17.
Scandurra, Giuseppa, et al.. (2019). Safety and efficacy of new techniques of radiotherapy in oligometastatic recurrent ovarian cancer patients with BRCA1/2 mutation. European Journal of Gynaecological Oncology. 40(5). 739–743. 2 indexed citations
18.
Gadducci, Angiolo, Valentina Guarneri, Fedro A. Peccatori, et al.. (2019). Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status. Journal of Ovarian Research. 12(1). 9–9. 82 indexed citations
19.
20.
Adamo, Vincenzo, Giosafat Spitaleri, Elisabetta Alafaci, et al.. (2005). Phase II Study of Gemcitabine and Cisplatin in Patients with Advanced or Metastatic Bladder Cancer: Long-Term Follow-Up of a 3-Week Regimen. Oncology. 69(5). 391–398. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven S. Evans Breakdown of academic impact, for papers by Chun Gao Breakdown of academic impact, for papers by Kimon Tzannis Breakdown of academic impact, for papers by Amira Elbendary Breakdown of academic impact, for papers by Constantine Dimitrakakis Breakdown of academic impact, for papers by Ensong Guo Breakdown of academic impact, for papers by Anwei Lu Breakdown of academic impact, for papers by Francis V. James Breakdown of academic impact, for papers by Yoo‐Kyung Lee
Rankless by CCL
2026